Profile data is unavailable for this security.
About the company
Mayinglong Pharmaceutical Group Co., Ltd. is a China-based company, principally engaged in pharmaceutical production, retailing and wholesaling businesses. The Company's pharmaceutical products are classified as drugs for hemorrhoid, including diosmin tablets, suppositories, pastes and granules, among others; drugs for cough, including levodropropizine oral solution and compound glycyrrhiza oral solution, as well as drugs for skin injuries, including products such as erythromycin ointment. The Company also provides specialty drugs. The Company is also engaged in the production and distribution of eye cream products with the brand named Mayinglong BaBao, as well as the provision of hospital clinical service. The Company distributes its products mainly in domestic markets.
- Revenue in CNY (TTM)3.42bn
- Net income in CNY473.79m
- Incorporated1994
- Employees2.88k
- LocationMayinglong Pharmaceutical Group Co LtdNo. 100, Nanhu Zhoujiawan, WuchangWUHAN 430064ChinaCHN
- Phone+86 2 787291519
- Fax+86 2 787291724
- Websitehttp://www.mayinglong.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GuangYuYuan Chinese Herbal Medicn Co Ltd | 1.28bn | 139.62m | 10.44bn | 1.81k | 74.75 | 6.71 | -- | 8.15 | 0.2852 | 0.2852 | 2.61 | 3.18 | 0.5043 | 0.6114 | 2.37 | 706,662.60 | 6.01 | -2.10 | 8.95 | -3.16 | 72.86 | 69.74 | 11.91 | -6.00 | 1.05 | 16.41 | 0.0597 | -- | 13.56 | -4.53 | 136.03 | -24.78 | -58.35 | -- |
Chongqing Genrix Biophrmctcl Co Ltd | 1.09m | -775.10m | 10.59bn | 547.00 | -- | 4.24 | -- | 9,706.59 | -2.11 | -2.11 | 0.003 | 6.81 | 0.0003 | 0.0628 | 53.97 | 1,995.17 | -20.89 | -- | -21.71 | -- | -214.22 | -- | -71,021.27 | -- | 20.06 | -- | 0.2053 | -- | 154.92 | -- | -39.03 | -- | -- | -- |
Mayinglong Pharmaceutical Group Co Ltd | 3.42bn | 473.79m | 11.16bn | 2.88k | 23.55 | 2.89 | -- | 3.26 | 1.10 | 1.10 | 7.94 | 8.94 | 0.6648 | 6.05 | 10.01 | 1,188,102.00 | 9.35 | 10.82 | 11.58 | 13.47 | 43.86 | 41.18 | 14.07 | 14.08 | 4.06 | -- | 0.0946 | 33.04 | -11.20 | 7.38 | -7.46 | 20.26 | 58.33 | 21.67 |
Heilongjiang ZBD Pharmaceutical Co Ltd | 2.22bn | 522.07m | 11.16bn | 2.55k | 21.33 | 1.41 | -- | 5.04 | 0.5556 | 0.5556 | 2.36 | 8.43 | 0.1757 | 0.6759 | 0.6464 | 870,758.90 | 4.10 | 3.48 | 5.54 | 4.78 | 64.84 | 38.93 | 23.37 | 10.08 | 2.18 | -- | 0.2951 | 27.18 | -25.50 | 2.45 | 155.00 | 0.4417 | -25.68 | 4.05 |
KPC Pharmaceuticals Inc | 7.49bn | 450.79m | 11.17bn | 5.05k | 24.85 | 2.08 | -- | 1.49 | 0.594 | 0.594 | 9.89 | 7.10 | 0.7847 | 2.43 | 2.66 | 1,482,262.00 | 4.79 | 5.42 | 8.10 | 9.13 | 41.97 | 43.68 | 6.11 | 5.70 | 1.44 | -- | 0.199 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
Guobang Pharma Ltd | 5.43bn | 659.59m | 11.48bn | 4.23k | 17.41 | 1.50 | -- | 2.11 | 1.18 | 1.18 | 9.72 | 13.70 | 0.5504 | 3.05 | 7.19 | 1,283,877.00 | 6.66 | 10.36 | 8.54 | 14.24 | 23.75 | 27.49 | 12.10 | 15.01 | 1.67 | -- | 0.1799 | 18.24 | -6.49 | 10.28 | -33.49 | 23.77 | 35.60 | -- |
Liaoning Chengda Biotechnology Co Ltd | 1.76bn | 352.53m | 11.66bn | 1.73k | 33.20 | 1.22 | -- | 6.63 | 0.8438 | 0.8438 | 4.23 | 22.93 | 0.1766 | 0.7386 | 1.48 | 1,015,870.00 | 3.54 | 10.63 | 3.66 | 11.01 | 81.24 | 85.74 | 20.04 | 39.56 | 17.34 | -- | 0.0019 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.42bn | 457.64m | 12.16bn | 8.41k | 26.66 | 1.78 | -- | 1.89 | 0.1775 | 0.1775 | 2.49 | 2.66 | 0.5903 | 2.44 | 4.39 | 762,894.60 | 4.66 | 6.77 | 6.76 | 10.50 | 52.88 | 63.24 | 7.90 | 11.10 | 1.30 | 26.89 | 0.109 | 42.32 | 12.20 | -0.8267 | 65.20 | -6.21 | -11.64 | 5.92 |
Holder | Shares | % Held |
---|---|---|
Bank of Communications Schroder Fund Management Co., Ltd.as of 31 Dec 2023 | 18.31m | 4.25% |
Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 7.78m | 1.81% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 3.39m | 0.79% |
First-Trust Fund Management Co., Ltd.as of 31 Dec 2023 | 2.32m | 0.54% |
Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 2.28m | 0.53% |
HFT Investment Management Co., Ltd.as of 31 Dec 2023 | 2.12m | 0.49% |
HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 1.99m | 0.46% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 1.84m | 0.43% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.70m | 0.40% |
First Seafront Fund Management Co., Ltd.as of 31 Dec 2023 | 1.41m | 0.33% |